LIST OF VITAL

ESSENTIAL AND
NECESSARY
DRUGS AND
MEDICAL SUNDRIES
FOR PUBLIC HEALTH
INSTITUTIONS

MINISTRY OH HEALTH & ENVIRONMENT JAMAICA

 SECTION 14. Vaccines and Related
CONTENTS Products
SECTION 15. Anaesthesia
Preface SECTION 16. Antidotes and Other
Message – Permanent Secretary (MOHE) Substances Used in
Message – Chief Medical Officer (MOHE) Poisoning
Information on Hospitals and Health Centres Medical Sundries
Explanatory Notes Dental Supplies
Prescription Writing Radiotherapy – Diagnostic Agents
List of Drugs Designated for NHF Raw Materials
List of Drugs Designated for JADEP Guidelines for Donation of Pharmaceuticals
Formulary Drug Request Form
CLASSIFICATION OF DRUGS
Drug Report Form
SECTION 1. Cardiovascular System
SECTION 2. Central Nervous System
SECTION 3. Dermatology
SECTION 4. Ear, Nose and Oropharynx
SECTION 5. Endocrine System
SECTION 6. Gastro-intestinal System
SECTION 7. Infections
SECTION 8. Malignant Disease and
Immunosuppression
SECTION 9. Musculoskeletal and Joint
Diseases
SECTION 10. Nutrition and Blood
SECTION 11. Ophthalmology
SECTION 12. Genito-Urinary Tract
Disorders
SECTION 13. Respiratory System
PREFACE
Message Permanent Secretary Message Chief Medical Officer
INFORMATION ON HOSPITALS AND HEALTH CENTRES EXPLANATORY NOTES

Service Delivery of the Public Health Care System is managed by four (4) 1. The column headed “Category” indicates the classification of the products
Regional Health Authorities. There are three hundred and twenty six (326) as Vital (V), Essential (E) or Necessary (N).
2. The Column headed “Institution” reflects the type of institution in and above
health institutions which comprise twenty-six (26) hospitals and three
which the product is designated for use. So that:
hundred (300) health centres.
o Where a number appears under the Institution column, the
product may be used in that type of Primary Care institution
Hospitals are categorised as Types A, B, C, Specialist and Community and upwards. Example: “3” means for use in Type 3 health
hospitals. The number of each type is as follows: centres up to Type A hospitals.
Type A 03 o Where a letter appears under the Institution column the
Type B 06 product is designated for use in that type of hospital and
Type C 08 upwards. Example: “C” means for use in Type C through to Type
Specialist 06 A hospitals.
Community 03 o Where a specific institution or out-patient clinic is named, the
product is designated for use in that institution/clinic only.
The specialist hospitals are:
1. Bellevue - Mental Health care ABBREVIATIONS AND SYMBOLS
2. Bustamante - Paediatric care BVH Bellevue Hospital
3. Hope Institute - Oncology care BHC Bustamante Hospital for Children
NCH National Chest Hospital
4. Sir John Golding
VJH Victoria Jubilee Hospital
Rehabilitation Center - Rehabilitative care for physically RU Renal Unit
challenged patients and paraplegics HCl Hydrochloride
5. National Chest - Cardio-thoracic care Inj. Injection
6. Victoria Jubilee - Obstetrics & Gynaecology care Susp. Suspension
Tab. Tablet
Public Health centres are classified as Types I through V and the allocation Oint. Ointment
is as follows: Co. Compound
Type I - 144 Soln. Solution
Type II - 83 Neb. Nebulization
Type III - 61 * Location specified at the end of the section
Type IV - 08 ¤ Restricted use; Consultant’s or Registrar’s authorization required,
Type V - 04 supported by C&S Tests where applicable
º Drugs in categories “E” and “N” will only be available on special
A Health Department is located in each parish and the office of the Medical request
Officer of Health is situated there. This department is responsible for - Available as Raw Material for manufacturing
supplies of vaccines and related products for the parish. © Controlled Drugs/Narcotics; appropriate storage measures required
 Prescription Writing - Prescriptions for controlled drugs must state the total quantity of the
[Pharmacy Regulation 20; Food and Drug Regulation 51(4)] drug to be dispensed.
- Prescriptions for controlled drugs can only be written by licensed
prescribers.
Prescribing of medicines should only be done when necessary and in - The names of drugs and related preparations must be written in
all cases should be subject to a risk-benefit analysis. full, not abbreviated.
- The units of measure, micrograms and nanograms, should be
Prescriptions for drugs or poison should be written clearly, in ink and written in full. Latin abbreviations for directions for use are
should include the following: acceptable.
- Unofficial abbreviations can be misinterpreted and should
a. The date of the prescription. therefore not be used.
b. The name and address of the person for whom the prescription is - Avoid the unnecessary use of decimal points. E.g. 50 mg not 50.0
issued. mg, 1G not 1.0 G, 500 mg not 0.5 G, 200 micrograms not 0.2 mg.
c. The name and quantity of the drug prescribed using the generic name. Where the use of a decimal is unavoidable a zero is to be placed
d. The name and address of the practitioner prescribing the drug. before the decimal point when no other number is present, E.g. 0.8
e. Adequate directions for use given with the prescription, and if that ml not .8ml
prescription is to be repeated, the number of times and intervals of time - When prescribing for infants, dose should preferably be calculated
at which it may be repeated; using the weight of the child rather than the age. See formula
f. The usual legible signature of the prescriber in ink. below.
g. The name and registration number of the prescriber should either
clearly written or stamped. patient’s weight in kg X adult dose
h. The name and address of the person receiving the prescription, if given 72
verbally.
i. Where the prescription is given by a registered dentist … the words “for
dental treatment only” … as the case may require.

The following guidelines are applicable, and when used can minimize
medication errors:
- The age of children 12 years and under must be stated.
- The dose, frequency and duration of medicines should be stated.
A minimum dose interval is to be given in cases where preparations
are to be used “as needed”.
- Suitable quantities of dermatological preparations should be stated.
- Prescriptions for controlled drugs should be written for a maximum
duration of two (2) weeks without repeats. A new prescription must
be written each time the patient requires the drug.
 List of Drugs Designated for The List of Drugs Designated for The
National Health Fund National Health Fund Contd.

Arthritis Benign Prostatic Hyperplasia Cardiovascular Contd. Cardiovascular Contd.

Acematicin Doxazosin Felodipine Verapamil
Azathioprine Finasteride Fluvaststin Benzathine Penicillin
Celecoxib Tamsulosin Fosinopril Benzylpenicillin
Diclofenac potassium Terazosin Fosinopril/HCTZ Phenoxymethyl penicillin
Diclofenac sodium Frusemide
Diclofenac + B1, B6, B12 Cancer Gemfibrozil
Bicalutamide Diabetes
Etoricoxib Hydralazine
Conjugated oestrogen Acarbose
Flubiprofen Hydrochlorothiazide (HCTZ)
Cyclophosphamide Glibenclamide
Hydroxychloroquin sulphate Indapamide SR
Cyproterone acetate Glibenclamide micronised
Ibuprofen Irbesartan
Fluorouracil Gliclazide
Indomethacin Isradipine
Flutamide Glimepiride
Ketoprofen Isosorbide Dinitrate
Goserelin Glipizide CR
Meloxicam Lacidipine
Letrozole Insulin
Methotrexate Lisinopril
Leuprolide Insulin 70/30
Naproxen Lisinopril/HCTZ
Mesna Insulin Aspartame
Piroxicam Losartan
Methotrexate Insulin Glargine
Prednisolone Losartan/HCTZ
Tamoxifen Insulin Lispro
Prednisone Lovastastin
Metformin
Sulindac Methyldopa
Cardiovascular Metformin/Glibenclamide
Metoprolol
Amlodipine Pioglitizone
Nadolol
Atenolol Repaglinide
Nifedipine
Atenolol/Chlorthalidone Rosiglitazone
Asthma Nifedipine Retard
Atrovaststin Rosiglitazone/Metformin
Beclomethasone Nitroglycerin
Budesonide Bendrofluazide Pentoxifylline
Bendrofluazide/Reserpine Epilepsy
Fenoterol hydrobromide Perindopril Carbamazepine
Fluticasone Bisoprolol Perindopril/Indapamide
Bisoprolol/HCTZ Divalproex sodium
Formoterol Potassium Chloride Gabapentin
Formoterol/Budesonide Candesartan Propranolol
Candesartan/HCTZ Oxcarbazepine
Ipratropium Bromide Provastatin Phenytoin
Montelukast Captopril Quinapril
Captopril/HCTZ Sodium valproate
Prednisolone Ramipril Topiramate
Prednisone Carvedilol Ramipril/HCTZ
Salbutamol Clopidogrel Reserpine/Clopamide/Dihydroergocristine Glaucoma
Salbutamol/Beclomethasone Diltiazem Rosuvastatin Acetazolamide
Salbutamol/Ipatropium Digoxin Simvastatin Betaxolol
Salmeterol Dipyridamole Sotalol Bimatoprost
Salmeterol/Fluticasone Enalapril Telmisartan Brimonidine
Theophylline Enalapril/HCTZ Telmisartan/HCTZ Brinzolamide
Tiotropium Ezetimibe Valsartan Canabis Sativa
Ezetimbe/Simvastatin Valsartan/HCTZ
List of Drugs Designated for The List of Drugs Designated for The
National Health Fund Contd. Jamaica Drugs for the Elderly
Programme
Glaucoma Contd.
Dorzolamide Arthirtis High Cholesterol
Dorzolamide/Timolol Diclofenac 50mg Simvastatin Tablets 10mg, 20mg
Latanoprost
Diclofenac SR Tablets 75mg Pravastatin Tablets 10mg, 20mg
Levobunolol
Pilocarpine Ibuprofen 400mg
Timolol Meloxicam Tablets 7.5mg, 15mg Hypertension &/or Cardiac Conditions
Travoprost Amlodipine Tablets 5mg, 10mg
Unoprostone Asthma Atenolol Tablets 50mg, 100mg
Beclomethasone Inhaler 50mcg/dose Bendrofluazide Tablets 2.5mg, 5mg
Psychiatry Salbutamol Inhaler 100mcg Bendrofluazide 5mg/Reserpine 0.15mg
Amitriptyline Salbutamol tablets 4mg Tablets (Combezide B)
Benztropine Captopril Tablets 25mg. 50mg
Bupropion Benign Prostatic Hyperplasia Digoxin Tablets 0.25mg
Carbamazepine Terazosin Tablets 1mg, 2mg, 5mg, 10mg Enalapril Tablets 5mg, 10mg, 20mg
Chlorpromazine Finasteride Tablets 5mg Frusemide Tablets 40mg
Citalopram
Indapamide SR Tablets 1.5mg
Clozapine
Divalproex Diabetes Isosorbide Dinitrate Tablets 10mg
Escitalopram Glibenclamide Tablets 5mg Losartan Tablets 25mg, 50mg
Fluoxetine Gliclazide tablets 80mg Methyldopa Tablets 250mg, 500mg
Fluphenazine Glicalzide MR Tablets 30mg Nifedipine SR Tablets 20mg
Haloperidol Metformin Tablets 500mg Potassium Chloride Tablets 600mg
Imipramine Metformin XR Tablets 500mg Trimetazidine Tablets 20mg
Lithium Carbonate Rosiglitazone Tablets 4mg, 8mg
Olanzapine Insulin Glargine Injection 100u/ml Psychotic Conditions
Oxcarbazepine
Insulin Isophane Injection 100u/ml Amitriptyline Tablets 25mg
Paroxetine
Quetiapine Insulin Regular Injection 100u/ml Benztropine Tablets 2mg
Risperdone Insulin 70:30 Injection 100u/ml Carbamazepine CR Tablets 200mg,
Sertraline 400mg
Sodium valproate Glaucoma Fluoxetine Tablets 20mg
Topiramate Acetazolamide Tablets 250mg Haloperidol Tablets 5mg
Trifluoperazine Betaxolol Eye Drops 0.25% Zuclopenthixol Oral drops 20mg/ml
Trihexyphenidyl Pilocarpine Eye Drops 2% 4%
Venlafaxine Timolol Eye Drops 0.25%, 0.5% Vascular Conditions
Zuclopenthixol
Canabis Sativa Eye Drops 0.1% Pentoxifylline Tablets 400mg
Diosmin / Hesperidin Tablets 500mg
Vinpocetine Forte Tablets 10mg
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 1 SECTION 1 (cont'd.)

1. CARDIOVASCULAR SYSTEM 1.3.3 Class 3

Amiodarone Injection 50 mg/ml V B
1.1 DIURETICS Amiodarone Tablet 100mg V B
Adenosine Injection 6mg V C
Bendrofluazide Tablets 2.5 mg, 5 mg V 3
Frusemide Tablets 40 mg V 3 1.3.4 Class 4 (Calcium Channel Blocker)
Frusemide Injection 10 mg/ ml V C Verapamil Tablets 80mg E C
Frusemide Paediatric Liquid 1 mg/ml V C Verapamil Injection 2.5 mg/ml V C
HydrochlorothiazideTablets 25 mg V 3
Indapamide SR Tablets 1.5 mg E 4 1.4 ANTI-HYPERTENSIVE THERAPY
Metolazone Tablets 5 mg N C
Spironolactone Tablets 25 mg E C 1.4.1 Vasodilators
Hydralazine Tablets 25 mg V 3
Hydralazine Injection 20 mg V 3
1.2 CARDIAC GLYCOSIDES Sildenafil Citrate Tabs. 50 mg E BHC
Minoxidil Tabs. 2.5mg, 5mg, 10mg E C
Digoxin Tablets 0.125 mg, 0.25 mg V 3
Digoxin Injection 0.25 mg/ ml V C 1.4.2 Centrally Acting Alpha-Agonist
Digoxin Elixir 0.05 mg/ml V C
Bendrofluazide 5mg/Reserpine 0.15mg E 3
1.3 ANTI-ARRHYTHMIC DRUGS Methyldopa Tablets 250 mg, 500 mg V 3

1.3.1 Class 1B 1.5 ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS

Lignocaine HCl Inj.10 mg/ml, 20 mg/ml V C ????
Captopril Tablets12.5 mg, 25 mg, 50 mg V 3
1.3.2 Class 2(Beta - Adrenergic Blocking Drugs) Enalapril Tablets 5 mg, 10 mg, 20 mg V 3
Atenolol Tablets 50 mg, 100 mg V 3 Lisinopril Tablets 5 mg, 10 mg E 3
Bisoprolol Tablets 5 mg, 10 mg N B Perindopril Tablets 2 mg E RU
Propranolol Tablets 10 mg, 40 mg, 80 mg, N 3 1.6 ANGIOTENSIN II RECEPTOR ANTAGONIST
Propranolol Injection 1 mg/ml E 5 Losartan Tablet 25 mg, 50 mg E C
Valsartan 40 mg, 80mg, 160mg Tablets N C
Valsartan/HCTZ 80/12.5 mg, 160/12.5 mg, N C
320/12.5 mg, 320/25 mg
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 1 (cont'd.) SECTION 1 (cont’d.)

1.7 ANTI-ANGINAL DRUGS 1.9 ANTI-COAGULANTAND ANTI-PLATELET DRUGS

Acetylsalicylic Acid Tablets 81mg E 3
1.7.1 Nitrates Clopidogrel Tablets 75 mg E 3
Isosorbide Dinitrate Tablets 10 mg V 3 Dalteparin Sodium Injection E C
Glyceryl Trinitrate Tablets 600 mcg V 3 12,500 units/ml, 25,000units/ml,
Glyceryl Trinitrate Injection 5 mg/ml V C Dipyridamole Tablets 25mg E 3
Enoxaparin Injection 20 mg/ml, 40 mg/ml, V C
100 mg/ml
1.7.2 Calcium Channel Blockers Heparin Injection 5,000 units/ml, V C
Amlodipine Tablets 5mg, 10mg E 3 10,000 Units/ml
Diltiazem Tablets 60 mg N C Warfarin Tablets 1 mg, 5 mg E 3
Nifedipine Capsules SL 10 mg E 3
1.10 HAEMOSTATICS
Nifedipine SR Tabs. 10mg, 20 mg, 30 mg N 3 Aminocaproic Acid Syrup 30 mg/ml V B
Aminocaproic Acid Injection 400 mg/ml V B
1.7.3 Beta-Adrenergic Blocking Drugs Factor VIII Fraction N B
See Section 1.3.2 Factor IX Fraction E B
Carvedilol Tablets 6.25 mg N B See 10.3.2 (Nutrition and Blood)
Labetalol Injection 5 mg/ml V B 1.11 LIPID LOWERING DRUGS
Metoprolol Injection 1 mg/ml N B
1.11.1 Anion Exchange Resins
1.8 SYMPATHOMIMETICS Cholestyramine Powder 4 G/sachet E C
Adrenaline Injection 0.1% V 3 1.11.2 Statins
Dobutamine Injection 12.5 mg, 50 mg V C Atorvastatin Tablets 10 mg, 20 mg E 3
Dopamine Injection 40 mg/ml V C Simvastatin Tablets 10 mg, 20 mg, 40 mg E 3
Ephedrine Injection 30 mg/ml, 50 mg/ml V 4
Metaraminol Injection10mg/ml V B 1.11.3 Other
Phenylephrine Injection 10mg/ml V B Ezetimibe Tablets 10 mg N 3
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 1 (cont’d.) SECTION 2

1.12 FIBRINOLYTIC 2. CENTRAL NERVOUS SYSTEM

Streptokinase Injection 250,000 Units E C 2.1 ANTICONVULSANTS
Tissue Plasminogen Activator V B Carbamazepine Syrup 100 mg/ml V 4
Carbamazepine Tablets 100 mg, 200 mg V 3
1.13 OTHER CARDIOVASCULAR DRUGS Clonazepam Tablets 0.5 mg, 20 mg V C
Diosmin 450 mg/Hesperidin 50 mg N ¤C Clonazepam Injection 1 mg/ml V C
Capsules Diazepam Suppository 10 mg E C
Milrinone Injection 1 mg/ml E B Fosphenytoin Injection 75mg/ml E B
Prostaglandin E1 Intravenous Solution V * Gabapentin Capsules 100 mg N *
Pentoxifylline Tablets 400 mg E 4 Oxcarbzepine Tablets 150 mg, N *
300 mg
Paraldehyde Injection 5ml N B
Phenytoin Sodium Injection 50 mg/ml V C
Phenytoin Sodium Tablets 50 mg V 3
Phenytoin Sodium Capsules 100 mg V 3
Phenytoin Sodium Susp. 125mg/5ml V 3
Sodium Valproate Tablets 200 mg V 3
Sodium Valproate Chrono Tabs. 200 mg,
300 mg, 500 mg
Sodium Valproate Syrup 200 mg/5ml V 3
Topiramate Tabs. 25mg, 50mg, 100mg E B
Valproic Acid Capsules 250 mg V 3
Valproic Acid Syrup 250 mg/5ml V 3
See Section 2.5
2.2 ANXIOLYTICS
Alprazolam Tabs. 0.25 mg, 0.5 mg, 1mg E C
Diazepam Tablets 2 mg, 5 mg V 3
Diazepam Injection 5 mg/ml V 3
Lorazepam Injection 4 mg/ml V C
Midazolam Tablets 7.5mg V C
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 2 (cont'd.) SECTION 2 (cont'd.)

2.3 ANTIDEPRESSANTS 2.4 ANTIPSYCHOTICS Contd.

Amitriptyline HydrochlorideTablets 25 mg V 3 Trifluoperazine Hydrochloride Tablets V 3

Fluoxetine Hydrochloride Tablets 20 mg V 3 1 mg, 5 mg
Imipramine HCl Tablets 10 mg, 25 mg E 3 Zuclopenthixol Dihydrochloride Tablets V C
Sertraline Tablets 50 mg, 100 mg E 5 10 mg, 20 mg
Zuclopenthixol Acetate Injection 50 mg/ml V C
Venlafaxine Tablets 37.5 mg, 75 mg E *
Zuclopenthixol Dihydrochloride Drops V *
20 mg/ml
Zuclopenthixol Decanoate Injection V 4
200 mg/ml
2.4 ANTIPSYCHOTICS

Chlorpromazine Hydrochloride Tablets V 3

25 mg, 100 mg 2.5 SEDATIVES
Chlorpromazine HCl Syrup 25 mg/ 5 ml V 4
Chlorpromazine Hydrochloride Injection V 3
25 mg / ml Phenobarbitone Sodium Injection V 4
Fluphenazine Decanoate Injection V C 200 mg/ml
25 mg/ml Phenobarbitone Tablets 15 mg, 30 mg V 3
Flupenthixol Decanoate Injection E 3 Phenobarbitone Elixir 15 mg/5 ml V C
20 mg/ml See Section 2.2 - Anxiolytics
Haloperidol Tablets 2 mg, 5 mg V 3 See Section 15 - Anaesthesia
Haloperidol Drops 1 mg/ml V 3
Haloperidol Injection 5 mg/ml V 3
Haloperidol Decanoate Injection V 3 2.6 DRUGS USED IN VERTIGO AND NAUSEA
50 mg/ml
Lithium Carbonate Tablets 250 mg E *
Cinnarizine Tablets 75mg E 5
Olanzapine Tablets 10 mg E * Dimenhydrinate Tablets 50 mg V 3
Quetiapine 100mg, 150mg, 200mg, 300mg E 5 Dimenhydrinate Injection 50 mg/ml V 3
Risperidone Tablets 1 mg, 2 mg E * Dimenhydrinate Suppositories 50 mg V C
Risperidone Injection 25 mg, 50 mg E *
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 2 (cont'd.) SECTION 2 (cont'd.)

2.6 DRUGS USED IN VERTIGO AND NAUSEA Contd. 2.7.1 Opioid Analgesics Contd.
Domperidone Tablets 10mg E B Tramadol Injection 50 mg, 100 mg E C
Domperidone Susp. 5 mg/ml E B Tramadol Tablets 50 mg E C
Levopromazine Injection 25 mg/ml E C
Prochlorperazine Maleate Tablets 5 mg V 3 2.7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
Prochlorperazine Mesylate Inj. 12.5 mg/ml V C Acetylsalicylic Acid Tablets 325 mg V 3
Promethazine Hydrochloride Tablets V C Diclofenac Sodium Tablets 50 mg, V 3
10 mg 75 mg, 100 mg
Promethazine HCl Injection 25 mg/ml V C Diclofenac Sodium Injection 75 mg/3ml V 4
2.7 ANALGESICS, ANTI-INFLAMMATORY AND ANTI-PYRETIC DRUGS Diclofenac Potassium Supp. 12.5mg E C
Diclofenac Potassium Drops 1.5% V 4
2.7.1 Opioid Analgesics Diclofenac Potassium Tabs. 25 mg, 50 mg V 3
©Codeine Phosphate Tablet 30 mg E C Diclofenac Potassium Susp. 9 mg/5ml V 4
Ibuprofen Syrup100 mg/5ml E 3
©Codeine Phosphate Oral Soln. 15mg/5ml E C
Ibuprofen Tablets 200 mg, 400 mg, 600 mg V 3
©Codeine Phosphate 30 mg/ Paracetamol E C
Mefenamic Acid Capsules 250 mg, 500mg N 3
500 mg Tablet
Metamizol Drops 500mg/ml E 4
©Fentanyl Patches 25, 50, 75, 100 E B
Metamizol Sodium Tabs. 500 mg E 4
©Methadone Tablets 5 mg E ¤B
Metamizol Sodium Injection 500 mg/ml E 4
©Methadone Injection 10 mg/ml E ¤B
Paracetamol Tablets 500 mg V 3
©Morphine Sulphate Tablets 10 mg, V C
Paracetamol Syrup 125 mg/5ml E 3
30 mg, 60 mg, 100 mg
Paracetamol Suppositories 125mg, 250mg E C
©Morphine Sulphate Injection 10 mg/ml, V C
15 mg/ml
2.8 DRUGS USED IN PARKINSONISM AND RELATED DISORDERS
©Morphine Oral Solution 10mg/5ml V C
©Oxycodone HCl Tablets 10 mg, 40 mg, E S
Benztropine Mesylate Tablets 2 mg V 3
80 mg
Benztropine Mesylate Injection 1mg/ml V 3
©Oxycodone HCl Injection 10 mg/ml E S
Levodopa 250mg / Carbidopa 25 mg V 3
Panadeine F Tablets E C
Tablets
©Pethidine Hydrochloride Injection V C
Trihexphenidyl Tablets 2 mg, 5 mg E 3
50 mg/ml, 100 mg/ml
Tramadol Drops 100 mg/ml E C
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 2 (cont'd.) SECTION 3

2.9 CENTRAL NERVOUS SYSTEM STIMULANT 3. DRUGS USED IN DERMATOLOGY

Methylphenidate Hydrochloride Tablets V B 3.1 ANTIBACTERIALS

10mg
Methylphenidate Tablets* 18mg, 36mg E B Fucidin Intertulle Dressing V 3
Framycetin Sulphate 1% Gauze Dressing V C
Mupirocin Ointment 2% V 4
Silver Sulphadiazine Cream 1% V 3
2.10 ACETYLCHOLINESTERASE INHIBITOR Sodium Fusidate Cream 2% E 4
Tetracycline Skin Ointment 3% V 3
Donepezil Tablets 5mg, 10mg * B BNT Ointment V 3
See Section 7.1 - Infections

* Bellevue and Regional Hospitals only

3.2 ACNE PREPARATIONS

Benzoyl Peroxide Gel 5%, 10% N 4

Clindamycin Solution 1% E *
Clindamycin Gel 1% N 5
Isotretinoin Capsule 5 mg, 20 mg N ¤B
Tretinoin Cream 0.025%, 0.05% E *
Salicyclic Acid 1% or 2% with Resorcinol E *
1% or 2% in 70% Alcohol
See Section 7.1 - Infections

3.3 ANTIFUNGALS

Ciclopirox Solution 1% E *
Clotrimazole Cream 1% V 3
Clotrimazole Solution 1% N 3
Econazole Cream 1% V 3
Ketoconazole Cream 2% N 3
Salicyclic Acid 3% / Benzoic Acid 6% N 4
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 3 (cont'd.) SECTION 3 (cont'd.)

3.3 ANTIFUNGALS Contd. 3.7 PARASITICIDES

Benzyl Benzoate Application 25% V 3
Schederma Cream (Isoconazole, N 5 Gamma Benzene Hexachloride Cream 1% E 3
Diflucortolone Valerate,)
Sodium Thiosulphate Solution 25% E 4 3.8 SKIN DISINFECTANTS
Sulphur Ointment 10% N 4 Cetrimide Cream 0.5% E 3
Terbinafine Cream 1% E 3 Cetrimide Lotion V 3
Povidone - Iodine Ointment 10% E 3
See Section 7.5 Infections Povidone – Iodine Solution 10% E 3

3.4 ANTIPRURITICS 3.9 SHAMPOOS

Cetrimide Solution 1% V 3
Calamine Lotion N 3 Ketoconozole shampoo 2% V 3
Selenium Sulphide 2.5% E C
3.5 ASTRINGENTS AND ANTISEPTIC DYES
3.10 OTHERS
Gentian Violet Paint 0.5% N 3 Aqueous Cream E C
Hydrogen Peroxide 6% (20 vols) E 3 Calcipotriol Ointment 50 mcg/g N ¤*
Potassium Permanganate Solution 0.1% V 3 Charcoal /Silver Impregnated Gauze V 3
Colagenase Gel N ¤B
3.6 CORTICOSTEROIDS Coal Tar Paste 0.5% E *
Emulsifying Ointment E 3
Betamethasone Scalp Application 1% V 4 Formaldehyde Solution 0.03% E 3
Betamethasone Valerate Cream 0.1% V 4 Ichthammol Compound N 3
Betamethasone Valerate Ointment 0.1% V 4 Formaldehyde Solution 0.03% E 3
Clobetasol Propionate Cream 0.05% V * Ketanserin Gel 2% V C
Clobetasol Propionate Ointment 0.05% V * Podophyllum Paint 25% V 5
Hydrocortisone Cream 1% V 3 Salicylic Acid Ointment 2%, 5% E 4
Hydrocortisone Ointment 1% V 3 Salicylic Acid Ointment 10%, 20% E *
Methylprednisolone Aceponate Oint. 0.1% V * Sulphur ppt. Ointment 2% E *
Methylprednisolone Aceponate Cream V * Tribenoside Capsule 400 mg V ¤B
0.1% Zinc Hyaluronan Gel N 3
See Section 5.3 - Endocrine System * Dermatology Clinics Only
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 4 SECTION 4 (cont’d)

4. DRUGS USED IN DISORDERS OF THE EAR, NOSE & OROPHARYNX 4.3 OROPHARYNX

4.1 EAR Chlorhexidine Mouth Wash 0.1%, 0.2% E 3

Dequalinium Lozenges 250 mcg E C
Auralgan Ear Drops N 3 Fusafungine Inhalation 1.18 g E C
Betamethasone Sodium Phosphate 0.1% Hydrogen Peroxide 6% (20 vols.) E 3
Ear Drops V 3 Kenalog in Orabase 0.1% N C
Boric Acid in Spirit Ear Drops 2% E 3
Chlorbutol Ear Drops 5% E C
Clotrimazole Solution 1% E 3
Chloramphenicol Ear Drops 5% V 3
Ciclopirox Olamine Soln. 10 mg/ml N 5 4.4 ANTI - INFECTIVES
Ciprofloxacin/ Hydrocortisone Ear Drops E C
Corticosporin Otic Drops E 3 See Section 7 – Infections
Gentamycin Sulphate Ear Drops 0.3% V C
4.5 OTHERS

See Section 13 – Respiratory System

4.2. NOSE

Beclomethasone Nasal Spray 50 mcg/dose E C

Betamethasone Sodium Phosphate 0.1%
with Neomycin Sulphate 0.5% Nose Drops V 3
Budesonide Nasal Spray 64 mcg/dose E C
Ephedrine in Normal Saline Nose Drops
0.5%, 1% E 3
Mometasone Nasal Spray 50 mcg/dose E C
Normal Saline Nose Drops E C
Oxymetazoline Nasal Spray 0.05% E 3
Pseudoephedrine HCl Tablets 60 mg E 5
Silver Nitrate Stick (long applicator) E 3
Xylometazoline Nasal Drops 0.5%, 1% N 3
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 5 Section 5 Contd.

5. DRUGS USED IN DISORDERS OF THE ENDOCRINE SYSTEM 5.3 CORTICOSTEROIDS

5.1 DRUGS USED IN DIABETES Cortisone acetate Tablets 25 mg E A

Dexamethasone Tablets 0.5 mg, 2mg, 4mg E C
Acarbose Tablets 50 mg, 100 mg N 5 Dexamethasone Sodium Phosphate V C
Glibenclamide Tablets 5 mg V 3 Injection 5 mg/ ml
Gliclazide MR Tablets 30 mg, 60 mg V 3 Hydrocortisone Sodium Succinate Injection V 3
Insulin Glargine 100 units/ml N S/B 100 mg
Insulin soluble 100 units/ml V 3 Methyl Prednisolone Injection 40mg/ml, V C
Insulin N 100 units/ml V 3 500 mg vial
Insulin 70/30 units/ml V 3 Prednisolone Tablets 5 mg V 3
Metformin Tablets 500 mg V 3 Prednisone Tablets 5 mg, 50 mg V 3
Metformin XR Tablets 500mg E 3
Metformin XR Tablets 850mg E 3 See Section 3 – Dermatology
Pioglitazone Tablets 15mg, 30mg, 45mg N C See Section 13.2 - Respiratory

5.4 HORMONES
5.2. THYROID AND ANTI-THYROID DRUGS
Conjugated Oestrogen Tablets E 4
Carbimazole Tablets 5 mg V 4 0.625 mg, 1.25 mg
L-Thyroxine Tabs 25, 50, 100 mcg V 3 Conjugated Oestrogen Injection E C
L-Thyroxine Sodium Tabs. 100 mcg V 4 60 mg/ml
Lugol’s Solution (Iodine) 5% V C Estradiol Valerate Tablets 1 mg, 2 mg N C
Propylthiouracil Tablets 50 mg V C Medroxyprogesterone Acetate Depot V C
Injection 150 mg/ml
Norethisterone Tablet 5 mg N C
5.2.2 Adjuvants Oxytocin Injection 10 units/ml V *C
Stilboestrol Diphosphate Tablets 1 mg, E C
See Section 1.3.2 - Tablets 5 mg
Stilboestrol Diphosphate Injection E C
60 mg/ml
Testosterone Enanthate Inj. 250 mg/ml N B
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

Section 5 Contd. SECTION 6

5.5 CONTRACEPTIVES 6. GASTRO-INTESTINAL SYSTEM

Levonorgestrel Implant (Norplant) N B 6.1 ANTACIDS

Low Dose Perle Tablets V 3
Lofeminal Tablets V 3 Aluminium Hydroxide 250 mg/ E 2
Levonorgestrel Tablets 750 mcg N * Magnesium Hydroxide 500mg/5ml Susp.
Bismuth Subsalicylate Suspension E 3
* Fertility Units and/or Assault Cases 262 mg/15ml
*

6.2 ANTISPASMODICS AND OTHER DRUGS ALTERING GUT MOTILITY

Metoclopramide Hydrochloride Tablets V 3

10mg
Metoclopramide Hydrochloride Injection V 4
5mg/ml
Metoclopramide Syrup 5 mg/ 5ml V 4

6.3 DRUS USED IN THE TREATMENT OF DIARRHOEA

6.3.1 Fluid and Electrolyte Replacement

Oral Rehydration Salts V 1

See Section 10.2.1 – Intravenous

Infusions

6.3.2 Antimotility drugs (not recommended for use in Gastroenteritis)

Diphenoxylate 2.5 mg/ Atropine 0.025 mg E 4
Tablets
Loperamide Hydrochloride Tablets 2 mg E 4
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 6 (cont'd.) SECTION 7

6.4 ULCER HEALING DRUGS 7. DRUGS USED IN THE TREATMENT OF INFECTIONS

Omeprazole Injection 40 mg V C 7.1 ANTIBIOTICS

Omeprazole Capsule 10 mg, 20 mg V 5
Pantoprazole Capsules 20 mg, 40 mg E 5 Amikacin Sulphate Injection 250mg/ml V ¤C
Pantoprazole Injection 40 mg V C Amikacin Sulphate Paediatric Injection V ¤C
Ranitidine Hydrochloride Tablets 150 mg, V 3 50mg/ml
300 mg Amoxycillin Sodium Injection 250mg, V C
Ranitidine Syrup 75 mg/5ml V 3 500mg
Ranitidine Hydrochloride Injection 25 mg/ml V C Amoxycillin Trihydrate Capsules 250 mg, V 3
Sucralfate Tablets 1 G E C 500 mg
Amoxycillin Trihydrate Suspension V 3
6.5 LAXATIVES/BOWEL CLEANSING SOLUTIONS 125 mg/5ml, 250 mg/5ml
Amoxycillin Trihydrate/ Clavulanic Acid V 3
Bisacodyl Tablets 5 mg N 3 Tablets 625mg, 1.2G
Bisacodyl Suppositories 5 mg,10 mg N 4 Amoxycillin Trihydrate/ Clavulanic Acid V 3
Glycerine Suppositories (paediatric & adult) N 3 Suspension 156 mg/ 5ml, 228mg/5ml,
Docusate Sodium Capsules 100 mg N C 457mg/5ml
Docusate Sodium Oral Solution N C Amoxicillin / Clavulanic Acid Injection V C
50 mcg/ml, 12.5 mcg/ml 600 mg, 1.2 G
Fleet Phospha Soda Oral Soln. V C Azithromycin Suspension 200 mg/5ml N 3
Fleet Enema V 5 Azithromycin Tablets 250 mg N 3
Sodium Picosulphate Drops N C Benzathine Penicillin Injection V 4
Macrogol Oral Powder N C 2,400,000 Units
Mineral oil V 3 Benzyl Penicillin Injection 1,000,000 Units V 4
Lactulose Powder 10 G Sachet N C Cefotaxime Sodium Injection 500mg, 1G E C
Ceftazidime Pentahydrate Injection E ¤C
6.6 OTHERS 250 mg, 500 mg,1G
Ceftriaxone Sodium Injection 250 mg, 1G E ¤C
Sulphasalazine Tablets 500 mg N B Cefuroxime Axetil Tablets 250 mg, 500 mg E C
Vasopressin Injection 20 mcg/ml V ¤B Cefuroxime Axetil Suspension 125 mg/5ml E C
See Section 5.3 (Corticosteroids) Cefuroxime Sodium Injection 750 mg, V C
1.5 G
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

Section 7 Contd. SECTION 7 (cont'd.)

7.1 ANTIBIOTICS (cont'd.) 7.1 ANTIBIOTICS (cont'd.)

Chloramphenicol Capsules 250 mg E 4 Piperacillin Sodium Injection 1G, 2G, 3G, V ¤B

Chloramphenicol Suspension 125 mg/5ml E 4 4G
Chloramphenicol Sodium Succinate E C Vancomycin Hydrochloride Injection 1G N ¤B
Injection 1G
Clarithromycin Tablets 250 mg, 500 mg E ¤C 7.2 ANTILEPROTIC DRUGS
Clindamycin Hydrochloride Capsules N 4
150 mg, 300 mg Clofazimine Capsules 100 mg V *
Clindamycin Phosphate Injection E C Dapsone Tablets 50 mg V *
150 mg/ml
Clindamycin Suspension 75mg/5ml E C 7.3 ANTITUBERCULAR DRUGS
Ciprofloxacin Hydrochloride Tablets N ¤C
250 mg, 500 mg Ethambutol Hydrochloride Tablets V *
Cloxacillin Suspension 125 mg/5ml V 3 250 mg
Cloxacillin Sodium Capsule 250 mg, V 3 Isoniazid Tablets 50 mg, 100 mg V *
500 mg Pyrazinamide Tablets 500 mg V *
Cloxacillin Sodium Injection 250 mg, V C Pyridoxine Tablets 400 mg V *
500 mg Rifabutin Tablets 300mg E *
Erythromycin Estolate Suspension V 3 Rifampicin Capsules 150 mg, 300 mg V *
200 mg/ 5 ml Rifampicin Syrup 100 mg/ 5 ml V *
Erythromycin Stearate Tablets 250 mg, V 3 Streptomycin Sulphate Inj. 1 g, 5 g V *
500mg V
Gentamycin Sulphate Injection V C 7.4 ANTIFUNGALS
10 mg/ml, 40 mg/ml
Imepenam Injection 250mg, 500mg V B Amphotericin B Injection 50 mg V *
Imipenem 500 mg/Cilastatin 500 mg Clotrimazole Mouth Paint V 3
Injection V B Fluconazole Capsules 50 mg, 150 mg, E C
Levofloxacin Injection 500 mg V B 200 mg
Meropenem Injection 500 mg N ¤B Griseofulvin Tablets125 mg, 500 mg E 3
Norfloxacin Tablets 400 mg E 4 Griseofulvin Suspension 125 mg/ 5 ml E 3
Procaine Penicillin Injection V 3 Itraconazole Capsules 100mg N C
3,000,000 Units Nystatin Oral Suspension 100,000 units/ml N 3
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 7 (cont'd.) SECTION 7 (cont’d)

7.4 ANTIFUNGALS Contd. 7.7 ANTIVIRALS

Nystatin Vaginal Tablets 100,000 units N 3 Efavirenz Tablets 600 mg V 4

Terbinafine Tablets 125 mg, 250 mg E 3 Ganciclovir Injection 500 mg E C
See Section 3.3 - Dermatology Indinavir Capsules 400 mg V 4
See Section 12 - G&U Disorders Lamivudine Tablets 150 mg V 4
Lamivudine Suspension 50 mg/5ml V C
7.5 ANTHELMINTICS Lopinavir 200mg/Ritonavir 50mg Tablets V 4
Lopinavir/Ritonavir Soln. 80/20 mg/ml V 4
Albendazole Tablets 200 mg E 3 Nevirapine Tablets 200 mg V 4
Albendazole Suspension 100 mg/5 ml E 3 Nevirapine Suspension 50 mg/ml V 4
Mebendazole Tablets 100 mg N 3 Oseltamivir Capsules 30 mg, 45 mg *E B
Mebendazole Suspension 100 mg/ 5 ml N 3 Ritonavir Capsules100 mg V 4
Stavudine Capsules 40 mg V C
7.6 ANTI-MALARIALS Tenofovir 245mg/Emtricitabine 200mg Tab. V 4
Zidovudine Tablets 300mg V 4
Chloroquine Phosphate Tablets 250 mg E 4 Zidovudine Capsules 100 mg, 250 mg V 4
Proguanil Hydrochloride Tablets 250 mg, N ¤4 Zidovudine Injection 10 mg/ml V 4
100 mg Zidovudine Suspension 50 mg/5ml V 4
Mefloquine Hydrochloride Tablets 250 mg N 4 Zidovudine 300mg + Lamivudine 150mg + V 4
Primaquin Tablets 7.5 mg N ¤C & Nevirapine 200mg Tablets
Quinine Injection 300 mg N B Zidovudine 300 mg/Lamivudine 150 mg V 4
7.7 ANTIVIRALS Tablets

Acyclovir Tablets 200 mg, 400 mg, 800 mg V 4 7.8 OTHER ANTI-INFECTIVES
Acyclovir Suspension 200 mg/5 ml V 4
Acyclovir Cream 5% E 4 Cotrimoxazole Tablets 480 mg V 3
Acyclovir Injection 250 mg, 500mg N C Cotrimoxazole Paediatric Suspension V 3
Abacavir Tablets 300mg E C 240 mg/ 5ml
Darunavir Tablets 300 mg E 4 Cotrimoxazole Injection 320 mg/ml E C
Didanosine Tablets 25 mg, 50 mg, 200 mg V 4 Metronidazole Tablets 200 mg, 250 mg, V 3
Didanosine Capsules 100 mg V 4 400 mg
Efavirenz Capsules 200 mg V 4 Metronidazole Injection 5 mg/ml N C
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 7 (cont’d) SECTION 8

7.8 OTHER ANTI-INFECTIVES Contd. 8. DRUGS USED IN TREATMENT OF MALIGNANT DISEASES AND FOR
IMMUNOSUPPRESSION
Metronidazole Suspension 200 mg/5ml N 3
Nalidixic Acid Tablets 500 mg E C 8.1 ALKYLATING DRUGS
Nitrofurantoin Tablets 100 mg N C
Pentamidine Injection 300mg N C Chlorambucil Tablets 2 mg V C
Pyrimethamine Tablets 25mg N ¤C Cyclophosphamide Tablets 50 mg, V C
Sulphadiazine Tablet 250mg, 500mg N C 100 mg, 500mg
Cyclophosphamide Injection 200 mg, 1G V C
* National Chest & Regional Hospital Only ºIfosfamide Injection 1G N B
ºLomustine (CCNU) Capsules 10 mg, E B
40 mg, 100 mg
ºLomustine (CCNU) Injection 10 mg E B
Melphalan Tablets 2 mg, 5 mg V C
*Mustine Hydrochloride Injection 10 mg V B
Temozolomide Caps. 5 mg, 20 mg, 100 mg N A

8.2 ANTIMETABOLITES

*Cytarabine Injection 100 mg V B

ºFludarabine Phosphate Injection E B
50 mg
5 - Fluorouracil Injection 25 mg/ml V C
ºFluorouracil Cream 5% N B
Gemcitabine Injection 200 mg N A
1, 6 Mercaptopurine Tablets 50 mg V B
Methotrexate Sodium Tablets 2.5 mg V C
Methotrexate Sodium Injection 50 mg V C
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 8 (cont'd.) SECTION 8 (cont'd.)

8.3 CYTOTOXIC ANTIBIOTICS 8.6 HORMONE ANTAGONISTS Contd.

Actinomycin D Injection 0.5 mg V B ºFinasteride Tablets 5 mg N B

ºBleomycin Sulphate Injection 15 mg E B Flutamide Tablets 250 mg N A
Daunorubicin Injection 50 mg N B ºGoserelin Acetate Implant 10.8 mg E B
Doxorubicin HCl Injection 50 mg/ml V C ºGoserelin Acetate Implant 3.6 mg E B
ºMitomycin Inj. 2 mg, 10 mg, 20 mg N B ºTamoxifen Citrate Tablets 10 mg E C
8.4 VINCA ALKALOIDS AND ETOPOSIDE Cytosine Arabinoside Injection 100 mg V B

ºEtoposide Injection 20 mg/ml N B 8.7 IMMUNOSUPPRESSANTS

ºVinblastine Sulphate Injection 1mg/ml E B
Vincristine Sulphate Injection 1 mg/ml V C ºMycophenolate Mofetil Tablets 500 mcg N B
ºMycophenolate Mofetil Injection 5 mg/ml N B
8.5 OTHER ANTINEOPLASTIC DRUGS Azathioprine Tablets 50 mg V B
See Section 9.3 – NSAID Drugs
ºL. Asparaginase Injection 10,000 Units E B 8.8 ADJUNCTS
Carboplatin Injection 10 mg/ml N A Calcium Folinate Tablet 15 mg E B
Bortezomib Injection 3.5 mg N A Calcium Folinate Injection 3 mg/ ml V B
Cisplatin Injection 50 mg, 100 mg V B ºFilgrastim Injection 300 mcg/ml N B
ºDacarbazine (DTIC) Injection 100 mg E B ºGranisetron Hydrochloride Tablets 1mg E B
Hydroxyurea Capsules 500 mg V B ºGranisetron Hydrochloride Injection E B
Leuprolide Injection 5 mg/ml N A 1 mg/ml
ºPaclitaxel Injection 6 mg/ml E B ºMesna Tablets 400mg, 600mg E B
Procarbazine HCl Capsules 50 mg V B ºMesna Injection 100mg/ml E B
Oxaliplatin Injection 50 mg, 100 mg N A Sodium Clodronate Intravenous Solution V A
30 mg/ml
8.6 HORMONE ANTAGONISTS Sodium Clodronate Tablets 520 mg V A
ºOndansetron Tablet 4 mg, 8 mg E B
ºAnastrozole Tablets1 mg N B ºOndansetron Injection 2 mg/ml E B
ºClomiphene Citrate Tablets 50 mg N B Prednisone Retention Enema 20 mg/100ml E C
Cyproterone Acetate Tablets 100mg N A
º NB. Drugs in Categories ‘E’ and ‘N’ will be available only on requests.
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 9 SECTION 9 (cont'd.)

9. DRUGS USED IN MUSCULOSKELETAL AND JOINT DISEASES 9.5 NEUROMUSCULAR DRUGS

9.1 NON-STEROIDAL ANTI-INFLAMMATORY (NSAIDs) DRUGS

Baclofen Tablet 10 mg E C
Diazepam Tablets 5 mg V 3
See Section 2.7.2 – CNS Diazepam Injection 5 mg/ml V 3
Edrophonium Chloride Injection
10 mg/ml N B
9.2 CORTICOSTEROIDS Neostigmine Bromide Tablets 15 mg V C
Orphenadrine Citrate Tablets 50 mg V C
See Section 5.3 - Endocrine System Pyridostigmine Bromide Tablets 60 mg V C

9.6 OTHERS
9.3 IMMUNOSUPPRESSANTS
Allopurinol Tablets 100 mg V C
Diclofenac Sodium Gel V 3
Chloroquine Phosphate Tablets 250 mg V 5
Probenecid Tablets 500 mg V 5
Cyclosporin Capsules 25 mg N B
Methylsalicylate Liniment V 3
Cyclosporin Oral Solution 100 mg/ml N B
Hydroxychloroquine Tablets 200 mg E 5
Sulphasalazine Tablets 500 mg E C
Etanercept Injection 25 mg N Aο
See Section 8.7 - Malignant Disorders

9.4 ANTIBIOTICS

Ceftriaxone Sodium Inj. 250 mg, 1G E C

Cefuroxime Sodium Inj. 750 mg, 1.5 G E C
Gentamycin Sulphate (Beads) E C
See Section 7 – Antibiotics
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 10 SECTION 10 (cont'd.)

10. DRUGS AFFECTING NUTRITION AND BLOOD 10.2.1 Intravenous Infusions

10.1 NUTRITION Albumin 25% - 50 ml N C

Amino Acid 10 % 500 ml N C
10.1.1 Vitamins Dextrose 20% in Water N C
Ascorbic Acid Tablets 50 mg, 1G N 3 Dextrose 4.3% in Normal Saline 500 ml V C
Folic Acid Tablets 5 mg V 3 Dextrose 5% in 1/2 Normal Saline 250 ml N C
Hydroxocobalamin Inj. 1,000 mcg/ml V 4 Dextrose 5% in Normal Saline 500 ml V 3
Multivitamin Syrup E 3 Dextrose 5% in Water 50 ml V 3
Multivitamin for Parenteral Use V C Dextrose 50% in Water 50 ml V 4
Pyridoxine tablet 50 mg, 10 mg N 4 Fractionated Ovolecithin 1.2% N C
Pyridoxine Injection E C Fractionated Soya Oil 10%, 20 % V C
Thiamine Hydrochloride Inj. 100 mg/ml V C Gelofusine V C
Thiamine Hydrochloride Tablets 100 mg V C Glycerol 2.5% N C
Vitamin B Complex Injection N C Hemodialysis Solution 5% 1,000 ml V A
Vitamin B Complex Tablets N 3 Mannitol 10%, 20% V C
See Section 10.3.2 - Haemostatics Peritoneal Dialysis Solution V A
Potassium Chloride 20 mEq/ ml vial V 4
10.2 FLUIDS AND ELECTROLYTES Sodium Bicarbonate 8.4% vial V 4
Calcium Acetate Tablets V RU Sodium Chloride 0.15%, 0.9%, 500 ml V 3
Calcium Chloride Injection 10% V C Sodium Chloride 3%, 6% 500 ml V C
Calcium Carbonate Tabs. 250 mg, 500 mg N RU Sodium Lactate Compound V 4
Calcium Gluconate Tablets 100 mg N C Water for Injection 2 ml, 5ml E C
Calcium Gluconate Injection 10% V C Water for Injection 500 ml Multidose Vial V 3
Calcium Phosphate Tablet N C
Calcitriol capsule 250 nanogram N RU 10.3 BLOOD
Calcitriol Injection 1 mcg/ml, 2 mcg/ml N RU
Oral Rehydration Salts V 1 10.3.1 Iron Preparations
Potassium Chloride Tablets 600 mg V 3
Potassium Chloride Injection 200 mEq V C Ferric Ammonium Citrate Compound N 3
-Potassium Chloride Mixture N C Tablets
500 mg/10 ml Ferrous Fumarate Tablets 200 mg E 3
-Potassium Citrate Mixture 3 G/10ml N 4 Ferrous Sulphate Compound Tablets E 3
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 10 (cont'd.) SECTION 11

10.3.1 Iron Preparations (cont'd.) 11. DRUGS USED IN OPHTHALMOLOGY

Ferrous Sulphate Compound Liquid E 3 11.1 MYDRIATICS AND CYCLOPLEGICS

Ferrous Sulphate Drops E 3
Iron - Dextran Complex 50 mg/ml V C Atropine Sulphate Eye Drops 1% V C
Iron and Multivitamin Tablets E 3 Cyclopentolate 1% Eye Drops E ¤B
Iron Sucrose Injection 20 mg/ml V RU Phenylephrine Hydrochloride Eye Drops E ¤B
2%, 10%
10.3.2 Haemostatics Tropicamide Eye Drops 1% E ¤B

Aminocaproic Acid Injection 400 mg/ml E C 11.2 MIOTICS AND DRUGS FOR TREATING GLAUCOMA
Aminocaproic Acid Syrup 300 mg/ml E C
Phytomenadione Injection 1 mg, 10 mg V C Acetazolamide Tablets 250 mg V C
Phytomenadione Tablets 10 mg N C Betaxolol Hydrochloride Eye Drops 0.25%, E C
Tranexamic Acid Tablet 500 mg N B 0.5%
Tranexamic Acid Injection 100 mg/ml N B Dorzolamide Eye Drops 2% E B
Dorzolamide 2%/ Timolol 0.5% Eye Drops N B
10.3.3 Other Preparations Pilocarpine Hydrochloride Eye Drops 1%, V C
2%, 3%, 4%
Epoetin Alfa Injection V RU Timolol Maleate Eye Drops 0.5%, 0.25% V C
Epoetin Beta Injection V RU Travaprost Eye Drops 0.004% E B

11.3 CORTICOSTEROIDS
10.4 OTHER FLUIDS
Betamethasone Sodium Phosphate Eye V C
Water for Irrigation 500ml, 1L E C Drops 0.1%
Betamethasone Sodium Injection 0.1% V ¤B
(for Subconjunctival use)
Dexamethasone Injection 4mg/ml (for E ¤B
Subconjunctival use)
Dexamethasone Eye Drops 0.1% N C C
Methylprednisolone Acetate Injection E C
40 mg/ml
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 11 (cont'd.) SECTION 12

11.4 ANTIBACTERIALS 12. DRUGS USED IN GENITO-URINARY TRACT DISORDERS

Betamethasone Sodium Phosphate 0.1% 12.1 DRUGS ACTING ON UTERINE MUSCLE

with Neomycin 0.5% Eye Drops V 3
Chloramphenicol Eye Drops 0.5% V 3 12.1.1 Uteronics
Chloramphenicol 0.5%/ Dexamethasone
0.1% Eye Drops V ¤C Oxytocin Injection 10 units/ml V 4
Ciprofloxacin 0.3% Eye Drops E C Methylergonovine Maleate Tablets 200 mcg V C
Ciprofloxacin 0.3% Eye Ointment E C Methylergonovine Maleate Inj. 200 mcg/ml V C
Gentamicin Eye Drops 0.3% N C Misoprostol Tablets 200 mcg N C
Gentamycin Injection (for Conjunctival use) V ¤B
Sulphacetamide Eye Drops 20% N 3
Tetracycline Eye Ointment 1% V 3 12.1.2 Uterine Muscle Relaxants

11.5 OTHERS Salbutamol Sulphate Tablets 2mg, 4 mg V 4

Salbutamol Sulphate Solution for
Acyclovir Eye Ointment 3% E C Nebulization 5mg/ml V C
Amethocaine Eye Drops 0.5% V ¤B Magnesium Sulphate Injection 50% Solution V C
Diclofenac Sodium Eye Drops 0.1% E C
Fluorescein Sodium Eye Drops 1%, 2% V ¤B 12.1.3 Uterine Muscle Vasoreactant Drug
Intra Ocular Lens V ¤B
Proxymetacaine Eye Drops 0.52% E ¤B Vasopressin Aqueous Solution
Silver Nitrate Eye Drops 1% V C 20 units/ml V B

See Section 7 - Infections.

12.2 OBSTETRIC CONDITIONS

Rhogam Injection 350 mcg V C

CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 12 (cont’d) SECTION 12 (cont’d)

12.3 DRUGS USED IN STD's 12.5 DRUGS USED FOR URINARY FREQUENCY, ENURESIS &
INCONTINENCE
Benzathine Penicillin Inj. 2,400,000 Units V 3
Ceftriaxone Injection 250 mg V 3 Oxybutynin Tablets 2.5 mg, 3 mg, 5 mg E B
Ciprofloxacin Tablets 250 mg, 500 mg E 4 Tolterodine SR Tablets 4 mg E B
Clotrimazole Pessaries 100 mg V 3
Clotrimazole Cream 1% V 3 12.6 OTHERS
Cotrimoxazole Tablets 480 mg N 3
Doxycycline Capsules 100 mg V 3 See Section 5.4 - Hormones; 5.5 - Oral Contraceptives
Erythromycin Tablets 250 mg, 500 mg V 3 See Section 8 - Malignant Disease
Fluconazole Capsule 150mg E 4
Metronidazole Suspension 100 mg/5ml V 3
Metronidazole Tablets 500 mg V 3
Norfloxacin Tablets 400 mg N 3
Podophyllin Paint 25% in Tr. Benzoin Co N 4
Procaine Penicillin Injection 3,000,000 Units V 3 4
Silver Nitrate Sticks E 3
Spectinomycin Injection 1G, 2G N 4

See Section 7 – Infections

12.4 DRUGS USED FOR URINARY RETENTION

Finasteride Tablets 5 mg V B
Phenazopyridine Tablets 100 mg E B
Terazosin Tablet 1 mg, 2 mg, 5 mg E B
Tamsulosin CRO Tablets 4 mg E B
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 13 SECTION 13 (cont'd.)

13. DRUGS USED IN TREATMENT OF DISORDERS OF THE 13.2 CORTICOSTEROIDS

RESPIRATORY SYSTEM
Beclomethasone Inhaler 50 mcg/metered
V 3
13.1 BRONCHODILATORS dose, 250 mcg/metered dose
Budesonide Soln. for Neb. 250 mcg/ml N C
Aminophylline Injection I.V. 250 mg/10ml V C Budesonide Turbohaler 100 mcg/dose E ¤*
Formoterol 160mcg/Budesonide 4.5mcg N C Budenoside/Fometerol Turbohaler
N ¤*
Metered Dose Inhaler (MDI) 4.5/80 mcg, 4.5/160 mcg
Ipratropium Bromide Nebuliser Solution Hydrocortisone Injection 100 mg/2ml,
V 4 V 3
250 mcg/ml 250 mg/2ml
Ipratropium Bromide Inhaler Methylprednisolone Injection 40 mg/ml V 4
E 4
20 mcg/metered dose Prednisolone Tablets 5 mg V 3
Salbutamol Inhaler 100 mcg/metered dose V 3 Prednisolone Syrup 15 mg/5ml V 3
Salbutamol Nebuliser Solution 5 mg/ml V 3 Prednisone Tablets 5 mg V 3
Salbutamol Syrup 2 mg/5ml E 3 Prednisone Tablets 50 mg N C
Salbutamol Tablets 2 mg, 4 mg E 3
Salbutamol Sulphate Expectorant 13.3 ANTIHISTAMINES
N 3
2mg/5ml
Salmeterol Inhaler 100 mcg/metered dose V 4 Chlorpheniramine Maleate Tablets 4 mg V 3
Salmeterol 250 mcg MDI E C Chlorpheniramine Syrup 2 mg/5ml
Theophylline Tablets 125 mg, 250 mg E 4 Clemastine Fumarate Tablets 1 mg N C
Terbutaline Injection 500 mcg/ml E C Diphenhydramine Hydrochloride Injection
V 3
Terbutaline Sulphate Tablets 5 mg E C 10 mg/ml
Terbutaline Sulphate Inhaler Diphenhydramine Hydrochloride Elixir
N C V 3
250 mcg/metered dose 12.5 mg/5ml
Terbutaline Nebuliser Solution 10mg/ml E C Diphenhydramine Hydrochloride Capsules
V 3
Theophylline Syrup N C 25 mg, 50 mg
Ketotifen Elixir 1 mg/5ml N 4
Loratidine 10 mg Tablets N 3
Loratidine Syrup 5 mg/5ml N 3
Promethazine Hydrochloride Tablets
E 3
10 mg, 25 mg
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 13 (cont'd.) SECTION 13 (cont'd.)

13.9 AROMATIC INHALATIONS
13.4 ANTI-INFECTIVES
Menthol Crystals N 3
See Section 7 – Infections Tincture Benzoin Compound 4.5% N 3

13.5 EXPECTORANTS AND COUGH SUPPRESSANTS 13.10 NASAL DECONGESTANTS

Ammonium Chloride Mixture E 3 See Section 4.2 – ENT Drugs

Bromhexine Hydrochloride Elixir 4mg/5ml,
E 4
8 mg/5ml
Codeine Phosphate 9 mg/
Promethazine Hydrochloride 3.6 mg/ 13. 11 OTHERS
Ephedrine Hydrochloride 7.25 mg/5 ml N 3
Syrup See Section 8 - Malignant Disorders
Dextromethorphan 7.5 mg/
Guaifenesin Syrup 100 mg/ * BHC, NCH & Regional Hospitals only
Pholcodeine 1.5 mg/
Promethazine Hydrochloride 1.5 mg/5ml N 4
Syrup
Diphenhydramine, 15 mg/
Ammonium Chloride 135 mg/
Sodium Citrate 57 mg / 5ml Syrup N 3
Linctus Codeine 15 mg/ 5 ml N C

13.6 RESPIRATORY STIMULANT

Ammonia Spirit N 1

13.7 PULMONARY SURFACTANT

Beractant Suspension 25 mg/ml E *

13.8 OXYGEN

Oxygen V 1
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 14 SECTION 15

14. VACCINES AND RELATED PRODUCTS 15. DRUGS USED IN ANAESTHESIA

Bacillus Calmette-Guerin (BCG) Vaccine V * 15.1 GENERAL ANAESTHESIA

Chicken Pox Vaccine (Varicella) Vaccine N ****
Diptheria Antitoxin (ADS) Injection V * 15.1.1 Peri-Operative Agents
Diptheria and Tetanus adsorbed (DT) (adult Alprazolam Tablet 0.5 mg N C
and child) Vaccine V * Atropine Sulphate Injection 0.6 mg/ml V C
Diptheria, Tetanus and Pertussis (DTP) Chloral Hydrate Paediatric Elixir 4% V C
Vaccine V * Glycopyrrollate Injection 0.2 mg/ml N C
DPT, Hepatitis B, Haemophilus Influenza Promethazine Hydrochloride Injection V C
Type B Combination Vaccine V * 25 mg/ml
Gas Gangrene Antitoxins (Mixed) V * Trimeprazine Tartrate Syrup 30 mg/5ml V C
Haemophilus Influenza Vaccine V *
Hepatitis B Vaccine V * 15.1.2 Intravenous Agents
Hepatitis B Immunoglobulin E C Etomidate Injection 2 mg/ml V C
Human Immunoglobulin V C Ketamine Hydrochloride Injection V C
Human Papilloma Virus Vaccine E *** 50 mg/ml
Influenza Vaccine V * Propofol Injection 10 mg/ml V C
Measles, Mumps and Rubella (MMR) Thiopentone Sodium Injection 0.5G, 1G V C
Vaccine V *
Pneumococcal Conjugate Vaccine E *** 15.1.3 Inhalation Agents
Poliomyelitis (OPV) Vaccine V * Halothane 50 ml N C
Poliomyelitis Inactivated Vaccine V * Isoflurane 250 ml V C
Tetanus Immunoglobulin V C Nitrous Oxide Gas V C
Tetanus Toxoid Adsorbed Vaccine V * Sevoflurane 250ml V C
Tuberculin (PPD) Vaccine V *
Yellow Fever Vaccine V *

*Available at all Parish Health Departments

*** To be introduced by 2009
**** To be introduced by 2010
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 15 (cont'd.) SECTION 15 (cont'd.)

15.1.4 Muscle Relaxants 15.1.6 Adjuvants (cont'd.)

Alcuronium Injection 5 mg/ml V C Sodium Citrate Solution 0.3mg V C

Cis-atracurium Injection 2 mg /ml V B Sodium Nitroprusside Injection 10 mg N C
Dantrolene Injection 20 mg N C Trimetaphan Camsylate Injection N C
Pancuronium Bromide Injection 4 mg/2ml NE C C 50 mg/ml
Suxamethonium Chloride Injection V C
50 mg/ml 15.1.7 Anticholinesterases
Neostigmine Methylsulphate Injection V C
15.1.5 Narcotics And Sedatives 2.5 mg/ml
©Codeine Phosphate Injection 60 mg/ml N B
©Droperidol Injection 2.5 mg/ml N C 15.1.8 Others
©Fetanyl Patches 25, 50, 75, 100 E B See Sections 1, 2, 5, 8, 9, 10, 13, 16
©Fentanyl Citrate Injection 50 mcg / ml E C
©Morphine Sulphate Injection 10 mg/ml V C 15.2 LOCAL ANAESTHESIA
©Pethidine Hydrochloride Injection V C
50 mg/ml Bupivacaine Hydrochloride Injection 0.25 %, E C
©Remifentanil Injection 1 mg N A 0.5%
Bupivacaine Hydrochloride Injection 0.75%
in Dextrose Water 8.25% E B
15.1.6 Adjuvants Bupivacaine 0.5%, Glucose 80 mg/ml V B
Esmolol Injecton 10mg/ml V B Injection
Flumazenil Injection 100 mcg/ml V B Lignocaine HCl Injection 0.5%, 1%, 2% V 3
Isoprenaline Injection 20 mcg V B Lignocaine Hydrochloride Injection 2% with
Labetolol Hydrochloride Injection N C Adrenaline 1: 200,000 V 3
5 mg/ml Lignocaine Hydrochloride Spray 10% N 3
©Naloxone Hydrochloride Injection V C
0.4 mg/ml Lignocaine 2.5% / Prilocaine 2.5% Cream E C
©Naloxone Hydrochloride Neonatal Injection V C Lignocaine 2% with Epinephrine Injection V 4
0.2 mg/ml 1:100,000
Noradrenaline Injection N C Lignocaine Patches E C
Phenylephrine Injection 1% V C Procainamide Injection 500 mg/ml N C
Ropivacaine Injection 0.2%, 0.75%, 1.0% E C
CLASSFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

SECTION 16 MEDICAL SUNDRIES

16. ANTIDOTES & OTHER SUBSTANCES USED IN POISONING  BANDAGES AND DRESSINGS

16.1 NON-SPECIFIC Bandage Tegaderm E C

Cotton Unbleached V 1
Activated Charcoal Powder V 5 Cotton Wadding V 1
Adrenaline Injection 0.1% V C Cotton Wool Absorbent Non-Sterile V 1
Atropine Sulphate Injection 1 mg V 4 Cotton Wool Non-Absorbent Sterile V 1
Calcium Gluconate Injection 100 mg/ml V 4 Gauze Absorbent V 1
Diazepam Injection 5 mg/ml V C Gauze Bandage (Elastic) 10 cm E 1
Fuller's Earth (Bentonite) V C Gauze Tube Bandage Applicators 2", 4", 8" E 1
Ipecacuanha Syrup 14 mg/10ml V 5 Lint Absorbent N 1
Plaster of Paris 7.5 cm, 15 cm, 20 cm V C
Plasters Extension 5 cm V 1
Surgicell V 1
16.2 SPECIFIC Tape Elastic Adhesive 5 cm, 7.5 cm, 10 cm V 1
Tape Micropore V 1
Acetylcysteine Injection 200 mg/ml V C  BLADES
Desferrioxamine Injection 500 mg V C
Dimercaprol Injection 50 mg/ml V C Blades Surgical #10, 15, 22 V 1
Flumazenil Injection 0.1 mg/ml V C Blades Surgical #20 E 1
Glucagon Injection 1 mg/ml V C Blades Surgical #11, 12 N 1
Naloxone HCl Injection 400 mcg/ml V C
Pralidoxime Mesylate Injection 200 mg/ml V C  CATHETERS AND TUBES
Protamine Sulphate Injection 50 mg/ml V C
Sodium Calcium Edetate Injection V C Cannulas Nasal V C
200 mg/ml Catheter Suction V C
Catheters Foley V 4
Catheters I V Placement 14, 16, 18, 20, 22, V 4
24
Catheters Umbilical V C
Central Venous Catheter irrigation sets, V C
Paediatric
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

MEDICAL SUNDRIES (cont'd.) MEDICAL SUNDRIES (cont'd.)

 CATHETERS AND TUBES (cont'd.)  OTHER SUNDRIES

Dialysis Catheter - Haemodialysis V B Airways with Introducer – adult, paediatric V C
Dialysis Catheter - Peritoneal V B Ambu Resuscitator Bags – paediatric, adult V 3
Tubes Argyle Chest Trocar # 10, 12, 14, V C Anaesthetic Extension Sets V C
16, 18 Autoclave Tapes V 2
Tubes Nasogastric E C Bags Colostomy E C
Endotracheal Tubes - adult, paediatric, Bags Urine (Adult & Paediatric) E C
neonates Bands Identification (colour coded) N C
Embolectomy Catheter (Fogarty) V C Blood Giving Sets V C
 GLOVES Blood Pumps V C
Gloves Elbow Sterile and Disposable E C Blood Glucose Test Kits, Strips & Lancets V 2
Gloves Disposable Sterile V 1 Body Bags E C
Gloves Disposable Medium, Large (Latex) V 1 Bone Marrow Biopsy Sets E A
Gloves Postmortem # 7.5, 8.5 E C Bottles Underwater Drainage V C
Gloves Surgeon (All Sizes) Sterile V 1 Cardiotocograph Machine & Paper Tracing V C
 NEEDLES SURGICAL Caps Nurses Disposable E 1
Central Venous Pressure sets 16g, 20g V C
Epidural Pack (MINI) E A Cricothyroidotomy Set (Emergency airway) V A
Needles Aspiration #14 V 4 Containers (Infectious Waste) N 1
Needles Disposable # 18, 19, 20, 21, 22, V 1 Containers plastic (Tablets) N 3
24, 25 G x 1.5" Cord Clamps – Hollister (Umbilical) V C
Needles Epidural 18 G E A Diathermy Leads & Pads V A
Needles Lumbar Puncture 3.5 cm , 6 cm E A ECG Leads V C
Needles Spinal #22, 24, 25, 26 G V B Eye Drop Bottles 15 ml E 3
Spinal sets E A Gowns Disposable (cuffed & uncuffed), E C
Sterile
 SYRINGES Gowns Disposable (cuffed & uncuffed), E C
Syringes Disposable Luerlock (All Sizes) V 1 Unsterile
Syringes Insulin 100 Units V 1 Humidifiers V C
Syringes Insulin 50 Units Intravenous Administration Sets V 4
Syringes Luerlock 50 cc, 20cc, 60cc N 1 Labels (Pharmaceuticals) N 3
Syringes 20cc without Luerlock V Mask Splash Guard (face shields) /V C
Masks Disposable V 1
CLASSIFICATION AND DRUG CATEGORY INSTITUTION CLASSIFICATION AND DRUG CATEGORY INSTITUTION

MEDICAL SUNDRIES MEDICAL SUNDRIES

OTHER SUNDRIES Contd. OTHER SUNDRIES Contd.

Masks with Ventilator N 4 Feeding Tubes (all sizes) V C
Maternity Pads N C Gauze Pledgets (peanut swabs) E C
Mersilene Tape for Cervical Cerclage V C Foetoscope V 3
Nebulizing Chambers V 3 Hand Sanitizers E 1
Oxygen Masks V 5 Indicator Strips V C
Oxygen Connectors V 3 Macintosh N C
Pads Incontinent N C Medication Cups E 2
Peak Flow Meters and Mouth Pieces N 3 Pampers – adult, paediatric E C
Portex Vaginal Pessaries 65, 70, 75, 80 N C Plastic Aprons N C
Sharps Containers V 1 Prolene Mesh V C
Sheeting Disposable N 2 Razor Sets E C
Slings – Figure 8 & Arm V 3 Scrub Brushes V C
Spacer (for inhalation) N C Soft Rolls E C
Specimen Containers V 3 Sterilizing Pouches V 3
Splints Various sizes E 4 S-Entry Mats E C
Stethoscopes V 2 Wrapping Paper (autoclave) V 3
Sutures V 2
Thermometers Digital, Mercury, Rectal V 1
Tongue Depressors N 3
Umbilical Cotton Tapes V C
Volumetric Sets (Paediatric) (Buretrol) V C
5mm Ethicon RS22 12” 30cm E C
Flexi-tip Enema Tips #s 9504, 9510, 9518, V BHC
9522
Air Contrast Flexi Tip #9322 V BHC
Colostomy Tips #s 9323, 9513, 9519 V BHC
Enema Retention Rings #s 820, 825 V BHC
Tubing, Y connection and Air Bulbs V BHC
Cover Shoes V C
Enema Sets V C
Eyeshields, Eyepads V 4
 DENTAL DEPARTMENT RADIOGRAPHY DEPARTMENT

Abrasive Paste Diagnostic Agents

Amalgam Pellets
Anaesthetic Topical Liquid Gastromiro Oral Iopamidol
Calcium Hydroxide Refill Optiray 320 - 75 ml, 125 ml
Cement Zinc Oxide Powder Ultravist 300 - 20ml, 50ml,100 ml
Camphor Parachlorophenol Fluid Urografin 76% - 50 ml, 100 ml
Cetylcide Solution/ Sterilant
Composite Material
Detergent Cleaner
Developer and Replenisher X-Ray
Eugenol
Formocresol
Guttapercha
I.R.M. Powder and Liquid
Lubricant H.P.
Mercury
Needles
Sealant
Solvent and Thinner
Surgical Blades
Sutures
Syringes
X-Ray Films
Zinc Oxide Powder
Zoe Cement (Powder and Liquid)
RAW MATERIALS GUIDELINES FOR DONATIONS OF PHARMACEUTICALS
Castor Oil Pulv. Amaranth
Compound Hydroxybenzoate Pulv. Ammonium Bicarbonate  The list of pharmaceuticals should be submitted to the Pharmaceutical
Crystal Chloral Hydrate Pulv. Ammonium Chloride and Regulatory Affairs Department, at least twenty-one (21) days,
Crystal Chlorocresol Pulv. Atropine prior to shipment by the donor, to determine the suitability of the
Crystal Citric Acid Pulv. Bentonite donation for public use.
Crystal Gentian Violet Pulv. Benzoic Acid
Crystal Iodine Pulv. Boric Acid  The appropriate drug importation permit should be obtained from the
Crystal Phenol Pulv. Calamine Pharmaceutical and Regulatory Affairs Department prior to arrival of the
Crystal Magnesium Sulphate Pulv. Chloramphenicol donation at the port of entry. There is a twenty-four (24) hour turn-
Crystal Potassium Chloride Pulv. Chlorhexidine (Acetate and around-time for approval of the permit application.
Crystal Potassium Citrate Gluconate)
Crystal Potassium Iodide Pulv. Chlorinated Lime  The donations should bear an expiry date of at least twelve (12)
Crystal Potassium Permanganate Pulv. Cocaine Hydrochloride months after landed date.
Crystal Silver Nitrate Pulv. Codeine Phosphate
Crystal Sodium Citrate Pulv. Ephedrine Hydrochloride  The brand or generic equivalent of a donation (drug) should be
Crystal Sodium Chloride Pulv. Flexible Colloidon registered for use in Jamaica except where the drug is to be
Crystal Sodium Thiosulphate Pulv. Fluorescein administered in emergency procedures e.g. invasive cardiovascular
Emulsifying Wax Pulv. Hydrocortisone Acetate or cerebral interventions.
Extract of Liquorice Pulv. Magnesium Carbonate
Liquid Acetic Acid Pulv. Magnesium Trisilicate  The Standards and Regulation Division reserves the right to
Liquid Acetone Pulv. Magneta detain/seize or cause to be re-exported, pharmaceuticals and other
Liquid Benzalkonium Pulv. Morphine Hydrochloride related products imported contrary to the guidelines. Failure to
Liquid Chloroform Pulv. Pilocarpine Nitrate comply with the guidelines is a breach of the FOOD AND DRUGS
Liquid Glycerine Phenyl Mercuric Nitrate ACT 1964, and FOOD AND DRUG REGULATIONS 1975.
Liquid Ichthammol Pulv. Precipitated Sulphur
Liquid Methylsalicylate Pulv. Salicylic Acid  Breaches of the CUSTOMS ACT 1941, may result in the imposition of
Liquid Paraffin (Light and Heavy) Pulv. Sodium Benzoate fines as deemed appropriate in keeping with that Act.
Liquid Propylene Glycol Pulv. Sodium Metabisulphite
Liquid Resorcinol Pulv. Zinc Oxide
Menthol Crystals Pulv. Zinc Sulphate
Oil Arachis Resin Podophyllum Pharmaceutical and Regulatory Affairs Department
Oil of Lemon Solution Coal Tar Ministry of Health & Environment
Oil of Peppermint Solution Formaldehyde 2008
Pulv. Acriflavine Syrup Tolu
Pulv. Amethocaine Hydrochloride Tincture Opii Camph
Pulv. Borax Yellow/White Soft Paraffin
 MINISTRY OF HEALTH AND ENVIRONMENT
CENTRAL DRUG & THERAPEUTICS COMMITTEE Section B: For official use only
FORMULARY DRUG REQUEST FORM
Decision of Central Drug &Therapeutics Committee
Application for addition, deletion or re-evaluation of a specific drug
o Approved
Section A: To be completed by physician or pharmacist o Refused

Name of drug (generic/trade) Dosage form(s) and strength(s) List of supporting documents received:

Indication(s): Dosage regimen(s):

Consultant contacted:

Your recommendation: If the recommendation is for deletion, please Registration status of drug nationally:
o Delete drug indicate reason(s)
o Add drug o New evidence drug is unsafe Registration status of drug internationally:
o Add drug with (provide supporting documents)
restrictions/guidelines o An equivalent drug on the General Comments:
o Re-evaluate drug formulary is more effective (state
name of drug)
o A more effective drug is being
recommended
o A less expensive drug is being
recommended
o Other (please state)

If the recommendation is for an addition/re-evaluation, please provide evidence base

documentation to support the following criteria.
o Efficacy
o Effectiveness
o Safety
o Financial impact

Name of Applicant Qualification/license # Chairman's Signature:

Date:
Place of Practice Telephone #/ fax Number #/ email
The completed form is to be forwarded to the Ministry of Health & Environment, Standards &
Regulation Division, Attention: Director.
Signature: Date: Telephone # 967-1100 -3 or 948-4106; Fax # 967-1629